Cardiovascular effects of breast cancer radiotherapy

Cancer Treatment Reviews

Volumn 33, Issue 6, 2007, Pages 578-593

  Senkus Konefka, Elzbieta ^a   Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Breast cancer; Cardiovascular complications; Radiotherapy

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; COBALT 60; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PACLITAXEL; TETROFOSMIN TC 99M; THALLIUM 201; TRASTUZUMAB;

ANGINA PECTORIS; ANGIOPLASTY; ATOMIC BOMB SURVIVOR; AUTOPSY; BLOOD VESSEL SHUNT; BREAST CANCER; BYPASS SURGERY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CATECHOLAMINE SYNTHESIS; CLINICAL FEATURE; COBALT THERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG USE; ELECTROCARDIOGRAPHY; ELECTRON THERAPY; ENDARTERECTOMY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FEVER; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PROTECTION; HEART SCINTISCANNING; HEART SURGERY; HODGKIN DISEASE; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; IONIZING RADIATION; ISCHEMIC HEART DISEASE; MASTECTOMY; MEDICAL ASSESSMENT; MORBIDITY; MORTALITY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PATHOPHYSIOLOGY; PERICARDITIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RECEPTOR DENSITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; VALVULAR HEART DISEASE; VASCULAR DISEASE; VASCULAR SURGERY;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; HUMANS; RADIATION INJURIES;

EID: 34548453107     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2007.07.011     Document Type: Review

References (160)

1. Adams M.J., Hardenbergh P.H., Constine L.S., and Lipshultz S.E. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 45 (2003) 55-75
2. Rutqvist L.E., Rose C., and Cavallin-Stahl E. A systematic overview of radiation therapy effects in breast cancer. Acta Oncol 42 (2003) 532-545
3. Cuzick J., Stewart H., Peto R., et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71 (1987) 15-29
4. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. N Engl J Med 1995;333:1444-55.
5. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000;355:1757-70.
6. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 (1994) 447-453
7. Hancock S.L., Tucker M.A., and Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270 (1993) 1949-1955
8. Hojris I., Overgaard M., Christensen J.J., and Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 354 (1999) 1425-1430
9. Vallis K.A., Pintilie M., Chong N., et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol 20 (2002) 1036-1042
10. Woodward W.A., Strom E.A., McNeese M.D., et al. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 327-335
11. Giordano S.H., Kuo Y.F., Freeman J.L., Buchholz T.A., Hortobagyi G.N., and Goodwin J.S. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97 (2005) 419-424
12. Patt D.A., Goodwin J.S., Kuo Y.F., et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 23 (2005) 7475-7482
13. Rutqvist L.E., Liedberg A., Hammar N., and Dalberg K. Myocardial infarction among women with early-stage breast cancer treated with conservative surgery and breast irradiation. Int J Radiat Oncol Biol Phys 40 (1998) 359-363
14. Nixon A.J., Manola J., Gelman R., et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol 16 (1998) 1374-1379
15. Corn B.W., Trock B.J., and Goodman R.L. Irradiation-related ischemic heart disease. J Clin Oncol 8 (1990) 741-750
16. Paszat L.F., Mackillop W.J., Groome P.A., Schulze K., and Holowaty E. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 43 (1999) 755-762
17. Darby S.C., McGale P., Taylor C.W., and Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6 (2005) 557-565
18. Darby S., McGale P., Peto R., Granath F., Hall P., and Ekbom A. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90,000 Swedish women. BMJ 326 (2003) 256-257
19. Taylor C.W., McGale P., and Darby S.C. Cardiac risks of breast-cancer radiotherapy: a contemporary view. Clin Oncol (R Coll Radiol) 18 (2006) 236-246
20. Carr Z.A., Land C.E., Kleinerman R.A., et al. Coronary heart disease after radiotherapy for peptic ulcer disease. Int J Radiat Oncol Biol Phys 61 (2005) 842-850
21. Huddart R.A., Norman A., Shahidi M., et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21 (2003) 1513-1523
22. Shimizu Y., Pierce D.A., Preston D.L., and Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990. Radiat Res 152 (1999) 374-389
23. Shapiro C.L., and Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med 344 (2001) 1997-2008
24. Prosnitz R.G., and Marks L.B. Radiation-induced heart disease: vigilance is still required. J Clin Oncol 23 (2005) 7391-7394
25. Hooning M.J., Aleman B.M., van Rosmalen A.J., Kuenen M.A., Klijn J.G., and van Leeuwen F.E. Cause-specific mortality in long-term survivors of breast cancer: a 25-year follow-up study. Int J Radiat Oncol Biol Phys 64 (2006) 1081-1091
26. Gagliardi G., Lax I., and Rutqvist L.E. Partial irradiation of the heart. Semin Radiat Oncol 11 (2001) 224-233
27. Brosius III F.C., Waller B.F., and Roberts W.C. Radiation heart disease. Analysis of 16 young (aged 15-33 years) necropsy patients who received over 3500 rads to the heart. Am J Med 70 (1981) 519-530
28. Stewart J.R., Fajardo L.F., Gillette S.M., and Constine L.S. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 31 (1995) 1205-1211
29. Seddon B., Cook A., Gothard L., et al. Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. Radiother Oncol 64 (2002) 53-63
30. Gyenes G. Radiation-induced ischemic heart disease in breast cancer - a review. Acta Oncol 37 (1998) 241-246
31. Schultz-Hector S., Bohm M., Blochel A., et al. Radiation-induced heart disease: morphology, changes in catecholamine synthesis and content, beta-adrenoceptor density, and hemodynamic function in an experimental model. Radiat Res 129 (1992) 281-289
32. Chello M., Mastroroberto P., Romano R., Zofrea S., Bevacqua I., and Marchese A.R. Changes in the proportion of types I and III collagen in the left ventricular wall of patients with post-irradiative pericarditis. Cardiovasc Surg 4 (1996) 222-226
33. Rodemann H.P., and Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol 35 (1995) 83-90
34. Fajardo L.F. The unique physiology of endothelial cells and its implications in radiobiology. Front Radiat Ther Oncol 23 (1989) 96-112
35. Rutqvist L.E., Lax I., Fornander T., and Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 22 (1992) 887-896
36. Yahalom J., and Portlock C.S. Adverse effects of treatment: section 4. cardiac toxicity. In: DeVita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer: principles and practice of oncology. 7th ed. (2005), Lippincott/Williams & Wilkins, Philadelphia (PA)/Baltimore (MD)
37. Fajardo L.F., Stewart J.R., and Cohn K.E. Morphology of radiation-induced heart disease. Arch Pathol 86 (1968) 512-519
38. Hull M.C., Morris C.G., Pepine C.J., and Mendenhall N.P. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA 290 (2003) 2831-2837
39. Carlson R.G., Mayfield W.R., Normann S., and Alexander J.A. Radiation-associated valvular disease. Chest 99 (1991) 538-545
40. Glanzmann C., Kaufmann P., Jenni R., Hess O.M., and Huguenin P. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 46 (1998) 51-62
41. Gyenes G., Fornander T., Carlens P., and Rutqvist L.E. Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 28 (1994) 1235-1241
42. Basavaraju S.R., and Easterly C.E. Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 29 (2002) 2391-2403
43. McEniery P.T., Dorosti K., Schiavone W.A., Pedrick T.J., and Sheldon W.C. Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol 60 (1987) 1020-1024
44. Veinot J.P., and Edwards W.D. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 27 (1996) 766-773
45. Amromin G.D., Gildenhorn H.L., Solomon R.D., and Nadkarni B.B. The synergism of X-irradiation and cholesterol-fat feeding on the development of coronary artery lesions. J Atheroscler Res 4 (1964) 325-334
46. Schultz-Hector S., and Trott K.R. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?. Int J Radiat Oncol Biol Phys 67 (2007) 10-18
47. Farago K., and Gyenes G. Pericardial irritation in breast cancer patients treated by curative postoperative radiotherapy - early results. Strahlenther Onkol 167 (1991) 201-207
48. Burns R.J., Bar-Shlomo B.Z., Druck M.N., et al. Detection of radiation cardiomyopathy by gated radionuclide angiography. Am J Med 74 (1983) 297-302
49. Heidenreich P.A., Hancock S.L., Vagelos R.H., Lee B.K., and Schnittger I. Diastolic dysfunction after mediastinal irradiation. Am Heart J 150 (2005) 977-982
50. Larsen R.L., Jakacki R.I., Vetter V.L., Meadows A.T., Silber J.H., and Barber G. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. Am J Cardiol 70 (1992) 73-77
51. Recht A. Which breast cancer patients should really worry about radiation-induced heart disease - and how much?. J Clin Oncol 24 (2006) 4059-4061
52. Orzan F., Brusca A., Conte M.R., Presbitero P., and Figliomeni M.C. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br Heart J 69 (1993) 496-500
53. Fuller S.A., Haybittle J.L., Smith R.E., and Dobbs H.J. Cardiac doses in post-operative breast irradiation. Radiother Oncol 25 (1992) 19-24
54. Gyenes G., Gagliardi G., Lax I., Fornander T., and Rutqvist L.E. Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol 15 (1997) 1348-1353
55. Reber D., Birnbaum D.E., and Tollenaere P. Heart diseases following mediastinal irradiation: surgical management. Eur J Cardiothorac Surg 9 (1995) 202-205
56. van Son J.A., Noyez L., and van Asten W.N. Use of internal mammary artery in myocardial revascularization after mediastinal irradiation. J Thorac Cardiovasc Surg 104 (1992) 1539-1544
57. Handa N., McGregor C.G., Danielson G.K., et al. Coronary artery bypass grafting in patients with previous mediastinal radiation therapy. J Thorac Cardiovasc Surg 117 (1999) 1136-1142
58. Host H., Brennhovd I.O., and Loeb M. Postoperative radiotherapy in breast cancer - long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12 (1986) 727-732
59. Haybittle J.L., Brinkley D., Houghton J., A'Hern R.P., and Baum M. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ 298 (1989) 1611-1614
60. Jones J.M., and Ribeiro G.G. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol 40 (1989) 204-208
61. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
62. Gyenes G., Rutqvist L.E., Liedberg A., and Fornander T. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 48 (1998) 185-190
63. Fisher B., Redmond C., Fisher E.R., et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312 (1985) 674-681
64. Fisher B., Anderson S., Redmond C.K., Wolmark N., Wickerham D.L., and Cronin W.M. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333 (1995) 1456-1461
65. Whelan T.J., Julian J., Wright J., Jadad A.R., and Levine M.L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
66. Hooning M.J., Botma A., Aleman B.M., et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99 (2007) 365-375
67. Gustavsson A., Bendahl P.O., Cwikiel M., Eskilsson J., Thapper K.L., and Pahlm O. No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer. Int J Radiat Oncol Biol Phys 43 (1999) 745-754
68. Gyenes G., Fornander T., Carlens P., Glas U., and Rutqvist L.E. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys 36 (1996) 899-905
69. Paszat L.F., Mackillop W.J., Groome P.A., Boyd C., Schulze K., and Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 16 (1998) 2625-2631
70. Adams M.J., Lipshultz S.E., Schwartz C., Fajardo L.F., Coen V., and Constine L.S. Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol 13 (2003) 346-356
71. Hurkmans C.W., Borger J.H., Bos L.J., et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol 55 (2000) 145-151
72. Cowen D., Gonzague-Casabianca L., Brenot-Rossi I., et al. Thallium-201 perfusion scintigraphy in the evaluation of late myocardial damage in left-side breast cancer treated with adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 41 (1998) 809-815
73. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
74. Harris E.E., Correa C., Hwang W.T., et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 24 (2006) 4100-4106
75. McGale P., and Darby S.C. Low doses of ionizing radiation and circulatory diseases: a systematic review of the published epidemiological evidence. Radiat Res 163 (2005) 247-257
76. Preston D.L., Shimizu Y., Pierce D.A., Suyama A., and Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 160 (2003) 381-407
77. Fossa SD, Chen J, Dores GM, McGlynn KA, Schonfeld LB, Travis LB. Long-term non-cancer mortality among 39,657 one-year testicular cancer survivors (TCSs). J Clin Oncol (ASCO Annual Meeting Proceedings Part I) 2006;24:4508.
78. Darby S.C., Doll R., Gill S.K., and Smith P.G. Long-term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 55 (1987) 179-190
79. Darby S.C., Reeves G., Key T., Doll R., and Stovall M. Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int J Cancer 56 (1994) 793-801
80. Davis F.G., Boice Jr. J.D., Hrubec Z., and Monson R.R. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res 49 (1989) 6130-6136
81. Hauptmann M., Mohan A.K., Doody M.M., Linet M.S., and Mabuchi K. Mortality from diseases of the circulatory system in radiologic technologists in the United States. Am J Epidemiol 157 (2003) 239-248
82. Berrington A., Darby S.C., Weiss H.A., and Doll R. 100 years of observation on British radiologists: mortality from cancer and other causes 1897-1997. Br J Radiol 74 (2001) 507-519
83. Matanoski G.M., Seltser R., Sartwell P.E., Diamond E.L., and Elliott E.A. The current mortality rates of radiologists and other physician specialists: specific causes of death. Am J Epidemiol 101 (1975) 199-210
84. Hayashi T., Kusunoki Y., Hakoda M., et al. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int J Radiat Biol 79 (2003) 129-136
85. Neriishi K., Nakashima E., and Delongchamp R.R. Persistent subclinical inflammation among A-bomb survivors. Int J Radiat Biol 77 (2001) 475-482
86. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 340 (1999) 115-126
87. Shapiro C.L., Hardenbergh P.H., Gelman R., et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 16 (1998) 3493-3501
88. Goethals I., Dierckx R., De Meerleer M.G., et al. The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage. J Nucl Med 44 (2003) 1531-1539
89. Lind P.A., Pagnanelli R., Marks L.B., et al. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys 55 (2003) 914-920
90. Lamont E.B., Christakis N.A., and Lauderdale D.S. Favorable cardiac risk among elderly breast carcinoma survivors. Cancer 98 (2003) 2-10
91. Zambetti M., Moliterni A., Materazzo C., et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. J Clin Oncol 19 (2001) 37-43
92. Tolba K.A., and Deliargyris E.N. Cardiotoxicity of cancer therapy. Cancer Invest 17 (1999) 408-422
93. Hardenbergh P.H., Munley M.T., Bentel G.C., et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys 49 (2001) 1023-1028
94. Theodoulou M., and Seidman A.D. Cardiac effects of adjuvant therapy for early breast cancer. Semin Oncol 30 (2003) 730-739
95. Touboul E., Lefranc J.P., Blondon J., et al. Multidisciplinary treatment approach to locally advanced non-inflammatory breast cancer using chemotherapy and radiotherapy with or without surgery. Radiother Oncol 25 (1992) 167-175
96. Blomqvist C., Tiusanen K., Elomaa I., et al. The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial. Br J Cancer 66 (1992) 1171-1176
97. Hardenberg P.H., Munley M., Hu C., et al. Doxorubicin-based chemotherapy and radiation increase cardiac perfusion changes in patients treated for left-sided breast cancer. Int J Radiat Oncol Biol Phys 51 Suppl. 1 (2001) 158
98. Halyard MY, Pisansky TM, Solin LJ, et al. Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: toxicity data from North Central Cancer Treatment Group Phase III trial N9831. J Clin Oncol (ASCO Annual Meeting Proceedings Part I) 2006;24:523.
99. Wondergem J., Strootman E.G., Frolich M., Leer J.W., and Noordijk E.M. Circulating atrial natriuretic peptide plasma levels as a marker for cardiac damage after radiotherapy. Radiother Oncol 58 (2001) 295-301
100. Morton D.L., Glancy D.L., Joseph W.L., and Adkins P.C. Management of patients with radiation-induced pericarditis with effusion: a note on the development of aortic regurgitation in two of them. Chest 64 (1973) 291-297
101. Stroobandt R., Knieriem H.-J., De W., and Joossens J.V. Radiation-induced heart disease. Acta Cardiol 30 (1975) 383-392
102. Persons C.C., Franken N.A., and Wondergem J. Changes in myocardial and circulating atrial natriuretic peptide following thorax irradiation in rat. Int J Radiat Biol 70 (1996) 61-68
103. Wondergem J., Persons K., Zurcher C., Frolich M., Leer J.W., and Broerse J. Changes in circulating atrial natriuretic peptide in relation to the cardiac status of Rhesus monkeys after total-body irradiation. Radiother Oncol 53 (1999) 67-75
104. Goethals I., De Winter W.O., De Bondt B.P., De Sutter S.J., Dierckx R., and Van de Wiele W.C. The clinical value of nuclear medicine in the assessment of irradiation-induced and anthracycline-associated cardiac damage. Ann Oncol 13 (2002) 1331-1339
105. Marks L.B., Yu X., Prosnitz R.G., et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 63 (2005) 214-223
106. Yu X, Zhou S, Kahn D, et al. Persistence of radiation (RT)-induced cardiac perfusion defects 3-5 years post-RT. J Clin Oncol (ASCO Annual Meeting Proceedings) 2004;22:625.
107. Hojris I., Sand N.P., Andersen J., Rehling M., and Overgaard M. Myocardial perfusion imaging in breast cancer patients treated with or without post-mastectomy radiotherapy. Radiother Oncol 55 (2000) 163-172
108. Yu X., Prosnitz R.R., Zhou S., et al. Symptomatic cardiac events following radiation therapy for left-sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion. Clin Breast Cancer 4 (2003) 193-197
109. 111In-Antimyosin myocardial scintigraphy In patients undergoing mediastinum or whole body irradiation. Eur J Nucl Med 19 (1992) 672
110. Valdes Olmos R.A., ten Bokkel Huinink W.W., Dewit L.G., Hoefnagel C.A., Liem I.H., and van T.H. Iodine-123 metaiodobenzylguanidine in the assessment of late cardiac effects from cancer therapy. Eur J Nucl Med 23 (1996) 453-458
111. Lagrange J.L., Darcourt J., Benoliel J., Bensadoun R.J., and Migneco O. Acute cardiac effects of mediastinal irradiation: assessment by radionuclide angiography. Int J Radiat Oncol Biol Phys 22 (1992) 897-903
112. Ikaheimo M.J., Niemela K.O., Linnaluoto M.M., Jakobsson M.J., Takkunen J.T., and Taskinen P.J. Early cardiac changes related to radiation therapy. Am J Cardiol 56 (1985) 943-946
113. Strender L.E., Lindahl J., and Larsson L.E. Incidence of heart disease and functional significance of changes in the electrocardiogram 10 years after radiotherapy for breast cancer. Cancer 57 (1986) 929-934
114. Krueger E.A., Schipper M.J., Koelling T., Marsh R.B., Butler J.B., and Pierce L.J. Cardiac chamber and coronary artery doses associated with postmastectomy radiotherapy techniques to the chest wall and regional nodes. Int J Radiat Oncol Biol Phys 60 (2004) 1195-1203
115. Prosnitz R.G., Chen Y.H., and Marks L.B. Cardiac toxicity following thoracic radiation. Semin Oncol 32 2 Suppl. 3 (2005) S71-S80
116. Das I.J., Cheng E.C., Freedman G., and Fowble B. Lung and heart dose volume analyses with CT simulator in radiation treatment of breast cancer. Int J Radiat Oncol Biol Phys 42 (1998) 11-19
117. Gagliardi G., Lax I., Soderstrom S., Gyenes G., and Rutqvist L.E. Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer. Radiother Oncol 46 (1998) 63-71
118. Magee B., Coyle C., Kirby M.C., Kane B., and Williams P.C. Use of electronic portal imaging to assess cardiac irradiation in breast radiotherapy. Clin Oncol (R Coll Radiol) 9 (1997) 259-261
119. Gagliardi G., Lax I., and Rutqvist L.E. Radiation therapy of stage I breast cancer: analysis of treatment technique accuracy using three-dimensional treatment planning tools. Radiother Oncol 24 (1992) 94-101
120. Lu H.M., Cash E., Chen M.H., et al. Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: a CT study. Int J Radiat Oncol Biol Phys 47 (2000) 895-904
121. Remouchamps V.M., Vicini F.A., Sharpe M.B., Kestin L.L., Martinez A.A., and Wong J.W. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 55 (2003) 392-406
122. Pedersen A.N., Korreman S., Nystrom H., and Specht L. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother Oncol 72 (2004) 53-60
123. Remouchamps V.M., Letts N., Vicini F.A., et al. Initial clinical experience with moderate deep-inspiration breath hold using an active breathing control device in the treatment of patients with left-sided breast cancer using external beam radiation therapy. Int J Radiat Oncol Biol Phys 56 (2003) 704-715
124. Krauss D.J., Kestin L.L., Raff G., et al. MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1243-1250
125. Korreman S.S., Pedersen A.N., Nottrup T.J., Specht L., and Nystrom H. Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique. Radiother Oncol 76 (2005) 311-318
126. Canney P.A., Sanderson R., Deehan C., and Wheldon T. Variation in the probability of cardiac complications with radiation technique in early breast cancer. Br J Radiol 74 (2001) 262-265
127. Canney P.A., Deehan C., Glegg M., and Dickson J. Reducing cardiac dose in post-operative irradiation of breast cancer patients: the relative importance of patient positioning and CT scan planning. Br J Radiol 72 (1999) 986-993
128. Hurkmans C.W., Borger J.H., Giersbergen A., Cho J., and Mijnheer B.J. Implementation of a forearm support to reduce the amount of irradiated lung and heart in radiation therapy of the breast. Radiother Oncol 61 (2001) 193-196
129. Canney P., Deehan C., Dickson J., and Glegg M. Developments in radiotherapy. Cancer Treat Rev 23 Suppl. 1 (1997) S23-S32
130. Griem K.L., Fetherston P., Kuznetsova M., Foster G.S., Shott S., and Chu J. Three-dimensional photon dosimetry: a comparison of treatment of the intact breast in the supine and prone position. Int J Radiat Oncol Biol Phys 57 (2003) 891-899
131. Campana F., Kirova Y.M., Rosenwald J.C., et al. Breast radiotherapy in the lateral decubitus position: a technique to prevent lung and heart irradiation. Int J Radiat Oncol Biol Phys 61 (2005) 1348-1354
132. Landau D., Adams E.J., Webb S., and Ross G. Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy. Radiother Oncol 60 (2001) 247-255
133. Raj K.A., Hardenberg P.H., Hollis D., et al. Local recurrence under the heart block in patients with left-sided breast cancer. Int J Radiat Oncol Biol Phys 60 Suppl. (2004) S403
134. Hojris I., Andersen J., Overgaard M., and Overgaard J. Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone. Acta Oncol 39 (2000) 355-372
135. Wennberg B., Gagliardi G., Sundbom L., Svane G., and Lind P. Early response of lung in breast cancer irradiation: radiologic density changes measured by CT and symptomatic radiation pneumonitis. Int J Radiat Oncol Biol Phys 52 (2002) 1196-1206
136. Kunkler I.H. Cardiovascular mortality after radiotherapy for breast cancer. Study showed only estimates of use of adjuvant radiotherapy. BMJ 326 (2003) 983-984
137. Fehlauer F., Tribius S., Holler U., et al. Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system. Int J Radiat Oncol Biol Phys 55 (2003) 651-658
138. Muren L.P., Maurstad G., Hafslund R., Anker G., and Dahl O. Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiother Oncol 62 (2002) 173-183
139. Hurkmans C.W., Cho B.C., Damen E., Zijp L., and Mijnheer B.J. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 62 (2002) 163-171
140. Cho B.C., Schwarz M., Mijnheer B.J., and Bartelink H. Simplified intensity-modulated radiotherapy using pre-defined segments to reduce cardiac complications in left-sided breast cancer. Radiother Oncol 70 (2004) 231-241
141. Cho B.C., Mijnheer B.J., and Bartelink H. Determining optimal two-beam axial orientations for heart sparing in left-sided breast cancer patients. Med Phys 31 (2004) 111-121
142. Pierce L.J., Butler J.B., Martel M.K., et al. Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys 52 (2002) 1220-1230
143. Arthur D.W., Arnfield M.R., Warwicke L.A., Morris M.M., and Zwicker R.D. Internal mammary node coverage: an investigation of presently accepted techniques. Int J Radiat Oncol Biol Phys 48 (2000) 139-146
144. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
145. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
146. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
147. Jagsi R., Griffith K.A., Koelling T., Roberts R., and Pierce L.J. Stroke rates and risk factors in patients treated with radiation therapy for early-stage breast cancer. J Clin Oncol 24 (2006) 2779-2785
148. Cheng S.W., Ting A.C., Lam L.K., and Wei W.I. Carotid stenosis after radiotherapy for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 126 (2000) 517-521
149. Dubec J.J., Munk P.L., Tsang V., et al. Carotid artery stenosis in patients who have undergone radiation therapy for head and neck malignancy. Br J Radiol 71 (1998) 872-875
150. Nilsson G., Holmberg L., Garmo H., Terent A., and Blomqvist C. Increased incidence of stroke in women with breast cancer. Eur J Cancer 41 (2005) 423-429
151. Woodward W.A., Giordano S.H., Duan Z., Hortobagyi G.N., and Buchholz T.A. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Cancer 106 (2006) 2556-2562
152. Hooning M.J., Dorresteijn L.D., Aleman B.M., et al. Decreased risk of stroke among 10-year survivors of breast cancer. J Clin Oncol 24 (2006) 5388-5394
153. Andros G., Schneider P.A., Harris R.W., Dulawa L.B., Oblath R.W., and Salles-Cunha S.X. Management of arterial occlusive disease following radiation therapy. Cardiovasc Surg 4 (1996) 135-142
154. Hassen-Khodja R., and Kieffer E. Radiotherapy-induced supra-aortic trunk disease: early and long-term results of surgical and endovascular reconstruction. J Vasc Surg 40 (2004) 254-261
155. Lewis J., Roberts J.T., and Gholkar A. Subclavian artery stenosis presenting as posterior cerebrovascular events after adjuvant radiotherapy for breast cancer. Clin Oncol (R Coll Radiol) 9 (1997) 122-123
156. Budin J.A., Casarella W.J., and Harisiadis L. Subclavian artery occlusion following radiotherapy for carcinoma of the breast. Radiology 118 (1976) 169-173
157. Hashmonai M., Elami A., Kuten A., Lichtig C., and Torem S. Subclavian artery occlusion after radiotherapy for carcinoma of the breast. Cancer 61 (1988) 2015-2018
158. Kretschmer G., Niederle B., Polterauer P., and Waneck R. Irradiation-induced changes in the subclavian and axillary arteries after radiotherapy for carcinoma of the breast. Surgery 99 (1986) 658-663
159. Mavor G.E., Kasenally A.T., Harper D.R., and Woodruff P.W. Thrombosis of the subclavian-axillary artery following radiotherapy for carcinoma of the breast. Br J Surg 60 (1973) 983-985
160. McCallion W.A., and Barros D'Sa A.A. Management of critical upper limb ischaemia long after irradiation injury of the subclavian and axillary arteries. Br J Surg 78 (1991) 1136-1138